PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
24-Oct-2023 ImmunOs Therapeutics Presents Overview of Phase 1a/b Trial of Lead Compound IOS-1002 ImmunOs Therapeutics
24-Oct-2023 Cantourage Group SE launches a range of high-THC medicinal cannabis flowers in Switzerland together with Astrasana Cantourage Group SE
23-Oct-2023 Marizyme CEO Delivers Business Update Marizyme, Inc.
23-Oct-2023 Eckert & Ziegler to Supply Ablaze Pharmaceuticals with Lutetium-177 for Clinical Trials Eckert & Ziegler Strahlen- und Medizintechnik AG
20-Oct-2023 Abivax announces trading resumption of its ordinary shares on Euronext Paris ABIVAX
20-Oct-2023 Eckert & Ziegler and Supervisory Board Decide on Investment Priorities for 2024: Focus on Core Competencies and Split-Off of Pentixapharm AG Eckert & Ziegler Strahlen- und Medizintechnik AG
20-Oct-2023 Eckert & Ziegler Focuses on Core Competence and Prepares Split-Off of Clinical Assets Eckert & Ziegler Strahlen- und Medizintechnik AG
20-Oct-2023 Almirall: Nearly 80% of patients with moderate-to-severe atopic dermatitis maintained clear or almost-clear skin with lebrikizumab monthly maintenance dosing at two years1 Almirall
20-Oct-2023 BRUKINSA® Receives Positive Recommendation from NICE in UK for Adult Patients with Chronic Lymphocytic Leukemia BeiGene, Ltd
20-Oct-2023 Abivax announces the pricing of its Initial Public Offering on the Nasdaq Global Market  ABIVAX
20-Oct-2023 Abivax announces temporary trading halt of its ordinary shares on Euronext Paris ABIVAX
20-Oct-2023 Montega AG includes Cantourage Group SE in its coverage with 'Buy' Cantourage Group SE
20-Oct-2023 PAION AG to issue approximately 4.8 million shares at EUR 1.90 per share in capital increase with subscription rights PAION AG
19-Oct-2023 PAION AG to issue approximately 4.8 million shares in capital increase with subscription rights PAION AG
19-Oct-2023 Original-Research: Sernova Corp (von First Berlin Equity Research GmbH) Sernova Corp
19-Oct-2023 Nanoformed TargTex oncology drug candidate TTX101 receives FDA Orphan Drug Designation Nanoform Finland Plc
19-Oct-2023 Invitation: Straumann Group 2023 third-quarter results webcast Straumann Holding AG
19-Oct-2023 4SC provides Q3 highlights and financial forecast 4SC
19-Oct-2023 New research highlights potential of iOnctura strategy combining autotaxin and TGF-β inhibitors in cancer iOnctura
19-Oct-2023 BC Platforms Partners with NTT to Accelerate Data-Driven Medicine in Japan BC Platforms (BCP)